CN104529855A - 一种含羟基金刚烷和酰胺结构的衍生物、其制备方法和用途 - Google Patents
一种含羟基金刚烷和酰胺结构的衍生物、其制备方法和用途 Download PDFInfo
- Publication number
- CN104529855A CN104529855A CN201510016738.1A CN201510016738A CN104529855A CN 104529855 A CN104529855 A CN 104529855A CN 201510016738 A CN201510016738 A CN 201510016738A CN 104529855 A CN104529855 A CN 104529855A
- Authority
- CN
- China
- Prior art keywords
- compound
- preparation
- acid
- formula
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510016738.1A CN104529855B (zh) | 2015-01-13 | 2015-01-13 | 一种含羟基金刚烷和酰胺结构的衍生物、其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510016738.1A CN104529855B (zh) | 2015-01-13 | 2015-01-13 | 一种含羟基金刚烷和酰胺结构的衍生物、其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104529855A true CN104529855A (zh) | 2015-04-22 |
CN104529855B CN104529855B (zh) | 2016-04-13 |
Family
ID=52845536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510016738.1A Active CN104529855B (zh) | 2015-01-13 | 2015-01-13 | 一种含羟基金刚烷和酰胺结构的衍生物、其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104529855B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006012441A1 (en) * | 2004-07-23 | 2006-02-02 | Susan Marie Royalty | Peptidase inhibitors |
CN101970402A (zh) * | 2008-03-05 | 2011-02-09 | 财团法人国家卫生研究院 | 吡咯烷化合物 |
CN103304498A (zh) * | 2013-06-02 | 2013-09-18 | 张远强 | 一种抗糖尿病化合物、其制备方法和用途 |
CN104003922A (zh) * | 2013-02-27 | 2014-08-27 | 中国药科大学 | 取代吡咯烷类衍生物及其制备方法和在医药上的用途 |
-
2015
- 2015-01-13 CN CN201510016738.1A patent/CN104529855B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006012441A1 (en) * | 2004-07-23 | 2006-02-02 | Susan Marie Royalty | Peptidase inhibitors |
CN101970402A (zh) * | 2008-03-05 | 2011-02-09 | 财团法人国家卫生研究院 | 吡咯烷化合物 |
CN104003922A (zh) * | 2013-02-27 | 2014-08-27 | 中国药科大学 | 取代吡咯烷类衍生物及其制备方法和在医药上的用途 |
CN103304498A (zh) * | 2013-06-02 | 2013-09-18 | 张远强 | 一种抗糖尿病化合物、其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN104529855B (zh) | 2016-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104529855B (zh) | 一种含羟基金刚烷和酰胺结构的衍生物、其制备方法和用途 | |
EP3978484A1 (en) | Heteroaromatic acetamide derivative, and preparation and use thereof | |
CN104447478B (zh) | 一种含腈基金刚烷和酰胺结构的衍生物、其制备方法和用途 | |
CN104447479B (zh) | 含金刚烷和酰胺类衍生物、其制备方法和用途 | |
CN104529857B (zh) | 卤代金刚烷酰胺类衍生物、其制备方法和用途 | |
CN104478778B (zh) | 金刚烷酰胺类衍生物、其制备方法和用途 | |
CN104496877B (zh) | 一种腈基金刚烷酰胺衍生物、其制备方法和用途 | |
CN104478777A (zh) | 一种含硝基金刚烷和酰胺结构的衍生物、其制备方法和用途 | |
CN104496876A (zh) | 一种羟基金刚烷酰胺衍生物、其制备方法和用途 | |
CN104530010B (zh) | 一种羟基金刚烷四氮唑化合物、其制备方法和用途 | |
CN104530011B (zh) | 一种腈基金刚烷四氮唑化合物、其制备方法和用途 | |
CN104529856A (zh) | 一种硝基金刚烷酰胺衍生物、其制备方法和用途 | |
CN104529858A (zh) | 含卤代金刚烷和酰胺类衍生物、其制备方法和用途 | |
CN104447704A (zh) | 一种腈基金刚烷四氮唑化合物、其制备方法和用途 | |
CN104478859A (zh) | 一种羟基金刚烷四氮唑化合物、其制备方法和用途 | |
CN104478861A (zh) | 一种硝基金刚烷四氮唑化合物、其制备方法和用途 | |
CN104530012B (zh) | 金刚烷胺四氮唑类衍生物、其制备方法和用途 | |
CN104478860A (zh) | 金刚烷四氮唑类衍生物、其制备方法和用途 | |
CN104530009A (zh) | 金刚烷胺四氮唑类衍生物、其制备方法和用途 | |
CN104496968A (zh) | 卤代金刚烷四氮唑结构的化合物、其制备方法和用途 | |
CN104447703A (zh) | 一种硝基金刚烷四氮唑化合物、其制备方法和用途 | |
Banoo et al. | Blood–brain barrier permeable benzylpiperidin‐4‐yl‐linked benzylamino benzamides as dual cholinesterase inhibitors | |
CA2879850A1 (en) | Xanthine derivative | |
CN104356046B (zh) | 环烷基取代的环己烷羧酸酰胺类衍生物及其用途 | |
CN102241644B (zh) | α-氨基-3-芳基丙酰胺基噻唑衍生物、其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Derivative containing hydroxyl adamantane and amide structure and preparation method and application thereof Effective date of registration: 20170816 Granted publication date: 20160413 Pledgee: Guangdong Nanhai Rural Commercial Bank branch branch of Limited by Share Ltd Pledgor: FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO., LTD. Registration number: 2017990000756 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190604 Granted publication date: 20160413 Pledgee: Guangdong Nanhai Rural Commercial Bank branch branch of Limited by Share Ltd Pledgor: FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO., LTD. Registration number: 2017990000756 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190729 Address after: 401120 No. 2 Huangyang Road, North Yubei District, Chongqing Patentee after: Fu'an Pharmaceutical Group Chongqing ceremony Pharmaceutical Development Co., Ltd. Address before: Chancheng district has 528000 Taiwan public in Guangdong province Foshan City No. 32 first floor 1636, shop No. 1637 Patentee before: FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right |